(no title)
bettercaust | 8 months ago
How are you qualifying this strategy as "ultra-high risk"? How well do you understand the new drug and vaccine regulatory process in the US? An "unsafe" (vague) vaccine will be discovered via postmarketing surveillance (e.g. Rotashield). If two unsafe vaccines are trialed comparatively and the adverse event rate is unusually high for both groups than what was previously reported, that's not going to go unnoticed even if it appears like there's no significant difference between the two statistically. Your concern also assumes that because the first approval was erroneous that all subsequent ones will be too, which is an unfounded assumption.
If you want to claim that the medical profession have "routinely lied as a group about many things in the past", you'll have to back that up because I don't agree and will not accept your assertion at face value.
No comments yet.